[0] ABIOMED, Inc. Splits Stock.Business Editors DANVERS, Mass.--(BUSINESS WIRE)--Oct. 2, 2000 ABIOMED, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ABMD ABMD areal bone mineral density ABMD AEGIS Ballistic Missile Defense (US Navy) ABMD Advanced Ballistic Missile Defense ) today announced that its two-for-one stock split is now effective. Beginning today, trading in shares of ABIOMED, Inc. reflects the stock split. Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced "AB-EE-O-MED") develops, manufactures and markets innovative cardiovascular products and is a leader in the research and development of advanced heart assist and heart replacement systems. The Company's BVS BVS Biblioteca Virtual em Saúde (Brazil) BVS Bureau of Vital Statistics BVS Brethren Volunteer Service (Church of the Brethren) BVS Boston Vegetarian Society (Cambridge, MA) (R) is the most widely used FDA-approved advanced cardiac assist device for patients with reversible heart failure. The Company's AbioCor(TM) and BeneCor(TM) implantable replacement hearts are in an advanced stages of development and are intended to extend the lives of patients with irreversible end-stage heart failure End-stage heart failure Severe heart disease that does not respond adequately to medical or surgical treatment. Mentioned in: Heart Transplantation . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion